GeoVax Labs share price logo

GeoVax Labs

NASDAQ: GOVX

$0.55

-0.06

(-9.18%)

as on

GeoVax Labs Stock Performance

as on September 3, 2026 at 6:59 am IST

  • Day's High

    $0.55
    $0.61

    10.91%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.59
    $19.21
    downward going graph

    -7.27%

    Downside

    3391.82%

    Upside

    downward going graph

GeoVax Labs share price movements today

Previous Close
$0.61
Open
$0.59
Volume
1.1M
Market Cap
$3.3M
Day's Low - High
$0.55 - $0.61
52 Week Low - High
$0.59 - $19.21

GeoVax Labs Historical Returns

1 Month Return
-11.1 %
3 Month Return
-71.16 %
1 Year Return
-96.73 %
3 Year Return
-99.72 %
5 Year Return
-99.97 %

GeoVax Labs Stock Fundamentals & Key Indicators

Check GeoVax Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.3M

EPS (TTM)

-13.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.05

Industry PE ratio

-1.4626335877862595

PEG Ratio

-0.0002658095399235746

EBITDA

-20.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-743.66%

GeoVax Labs Stock Valuation

Track how GeoVax Labs P/E has moved over time to understand its valuation trends.

GeoVax Labs in the last 5 years

  • Overview

  • Trends

Lowest (-7.43x)

December 31, 2021

Industry (-1.46x)

December 31, 2025

Today (-0.19x)

December 31, 2025

Highest (-0.19x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.19x

GeoVax Labs vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GeoVax Labs with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
GeoVax Labs image
GeoVax Labs
BUY$3.3M-99.97%-0.050.00%NA
Revolution Medicines image
Revolution Medicines
BUY$44.6B614.61%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$137.9B174.9%31.9286.04%NA
Moderna image
Moderna
BUY$61.6B-61.21%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for GeoVax Labs Stock including INR - Dollar returns

The GeoVax Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

GeoVax Labs investment value today

Current value as on today

₹3,209

Returns

-₹96,791

(-96.79%)

Returns from GeoVax Labs Stock

-₹97,027 (-97.03%)

Dollar Impact

₹235 (+0.24%)

Analyst Recommendation on GeoVax Labs Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for GeoVax Labs. Average target price of $10

GeoVax Labs Share Price Target

Get share price movements and forecasts by analysts on GeoVax Labs.

What analysts predicted

94.5%UPSIDE

Target Price

$10

Current Price

$0.55

Analyzed by

1 Analysts

Target

$10.00

GeoVax Labs target price $10, a slight upside of 94.5% compared to current price of $0.55. According to 1 analysts rating.

Indian Investors' Interest in GeoVax Labs Stock

Search interest for GeoVax Labs Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-21% versus previous 30 day period

GeoVax Labs Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
2
0
1
0
-
-
-
-
Gross Profit
0
-3
-4
0
-3
-3
-5
0
-3
0
Operating Income
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
EBITDA
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Interest Expense
-
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Net Profit Margin
0.00%
100.00%
100.00%
97.50%
-227.12%
-454.86%
0.00%
0.00%
0.00%
0.00%

GeoVax Labs Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
1
1
0
0
-
3
2
Gross Profit
0
0
1
1
-15
-9
-20
3
-15
Operating Income
-2
-2
-2
-2
-18
-14
-26
-25
-21
EBITDA
-2
-2
-2
-2
-18
-13
-25
-24
-21
Interest Expense
-
0
0
0
0
-
-
0
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-2
-2
-18
-14
-25
-24
-21
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
-2
-2
-2
-2
-18
-14
-25
-24
-21
Net Profit Margin
-87.61%
-95.08%
100.00%
100.00%
100.00%
-11090.88%
0.00%
97.59%
-628.02%

GeoVax Labs Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Operating Cash Flow
-5
-1
-9
-7
-5
-4
-6
-4
-3
-3
Investing Cash Flow
-
-
0
-
0
0
-
-
-
-
Financing Cash Flow
-
2
16
4
7
0
8
3
1
5
Change in Cash
-5
0
7
-3
1
-4
1
-1
-1
1

GeoVax Labs Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-2
-2
-2
-18
-14
-25
-24
-21
Operating Cash Flow
-1
-1
-1
-2
-11
-19
-25
-24
-21
Investing Cash Flow
0
-
0
0
0
0
0
0
0
Financing Cash Flow
1
1
1
12
12
35
4
23
19
Change in Cash
0
0
0
9
1
16
-21
0
-2

Mutual Funds that own GeoVax Labs Stock

Check out the Mutual Funds with significant holdings in GeoVax Labs.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.187129%
13790
VANGUARD INDEX FUNDS
0.043654%
3217

Global Institutional Holdings in GeoVax Labs

Funds
Holdings
Vanguard
0.04%

GeoVax Labs News & Key Events

  • img

    Today's Timeline - 28 August

    Sat, 02:18 AM

    -

    GeoVax Labs faces Nasdaq delisting due to low stock price; plans to appeal by September 3, 2026.

    Sat, 02:23 AM

    -

    GeoVax Labs completes warrant exercise, raising $3.65 million for working capital and vaccine development.

Insights on GeoVax Labs

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 634.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 37.1% return, outperforming this stock by 136.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, GOVX stock has moved down by -71.2%

About GeoVax Labs

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
OrganisationGeoVax Labs
Headquarters1955 Lake Park Drive, Smyrna, GA, United States, 30080
IndustryBiotechnology
CEOMr. David Alan Dodd
E-voting on sharesClick here to vote

Key Management of GeoVax Labs

Name

Title

Mr. Jeffrey Welch

Head of Process Development & Manufacturing Operations

Mr. David Alan Dodd

Chairman, President & CEO

Dr. Mark J. Newman Ph.D.

Chief Scientific Officer

Dr. Kelly T. McKee Jr., M.D., M.P.H.

Chief Medical Officer

Mr. Thomas O'Brien

Vice President of Quality Systems & Compliance

FAQs

What is GeoVax Labs share price today?

GeoVax Labs share price today is $0.55 as on at the close of the market. GeoVax Labs share today touched a day high of $0.61 and a low of $0.55.

What is the 52 week high and 52 week low for GeoVax Labs share?

GeoVax Labs share touched a 52 week high of $19.21 on and a 52 week low of $0.59 on . GeoVax Labs stock price today i.e. is closed at $0.55,which is 97.14% down from its 52 week high and -6.78% up from its 52 week low.

What is GeoVax Labs's market capitalisation today?

GeoVax Labs market capitalisation is $0.00T as on .

How to invest in GeoVax Labs Stock (GOVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GeoVax Labs on INDmoney app. Click on Buy button. You can invest as low as $1.5 in GeoVax Labs Shares that will get you 2.7273 shares as per GeoVax Labs share price of $0.55 per share as on September 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy GeoVax Labs Stock (GOVX) from India?

Indian investors can start investing in GeoVax Labs (GOVX) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in GeoVax Labs stock (as per the Rupee-Dollar exchange rate as on ). Based on GeoVax Labs share’s latest price of $0.55 as on September 3, 2026 at 1:29 am IST, you will get 18.1818 shares of GeoVax Labs. Learn more about fractional shares .

What are the returns that GeoVax Labs has given to Indian investors in the last 5 years?

GeoVax Labs stock has given -99.97% share price returns and 30.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?